Sunpeaks Ventures Announces Second Quarter 2012 Results
SILVER SPRING, Md., Aug. 14, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") on 8/14/12 reported its financial results for the second quarter ended June 30, 2012:
Second Quarter Financial Details and Operating Summary
- Gross sales for the second quarter were $1.23 mln on a non-adjusted basis. Gross sales for the year-to-date were $2.19mln on a non-adjusted basis. Second quarter revenue in 2012 represents a 4,000% increase over revenue for the same quarter in 2012, and a 29% increase over revenue for the first quarter of 2012.
- The Company continues to grow its pharmaceutical license base and is now licensed in 30 states.
- The Company continues to make a significant investment in its IT infrastructure, which management believes will stream line sales processes and lead to greater efficiencies.
- The Company attended the ERCM Marketgate, Vitamin, Diet and Nutrition conference in Ft. Lauderdale, FL, and as a result expects to enter into new agreements regarding the distribution of Clotamin sometime in the second half of 2012.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.
For additional information, please visit www.sunpeaksventures.com.
Contact: Financial Insights 888-248-8491 or firstname.lastname@example.org
Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
SOURCE Sunpeaks Ventures, Inc.
More by this Source
Sunpeaks Ventures Announces Name Change to Pharmagen, Inc.
Jan 14, 2013, 09:24 ET
Sunpeaks Ventures Announces Hiring of Chief Financial Officer
Dec 27, 2012, 13:58 ET
Sunpeaks Ventures Closes $7.5MM Committed Equity Facility with TCA Global Credit Master Fund
Dec 17, 2012, 17:20 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.